Flowserve Corporation (FLS) had a active trading with around 2.01M shares changing hands compared to its three month average trading volume of 1.25M. The stock traded between $50.63 and $51.25 before closing at the price of $51.2 with 0.53% change on the day. The Irving Texas 75039 based company is currently trading 31.36% above its 52 week low of $39.13 and -1.73% below its 52 week high of $52.5. Both the RSI indicator and target price of 58.32 and $48.64 respectively, lead us to believe that it should be put on hold over the coming weeks.
Flowserve Corporation designs, manufactures, distributes, and services industrial flow management equipment worldwide. The company operates through three segments: Engineered Product Division (EPD), Industrial Product Division (IPD), and Flow Control Division (FCD). The EPD segment offers custom and other engineered pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, and related services, as well as manufactures gas-lubricated mechanical seals used in high-speed compressors. The IPD segment provides pre-configured engineered pumps and pump systems, and related products and services, including submersible motors and specialty products. The FCD segment offers industrial valve and automation solutions comprising isolation and control valves, actuation, controls, and related equipment; and energy management products, such as steam traps, boiler controls and condensate, and energy recovery systems. Its products are used to control, direct, and manage the flow of liquids and gases. The company also offers aftermarket equipment services consisting of installation, advanced diagnostics, repair, and retrofitting. It primarily serves oil and gas, chemical, power generation, and water management markets, as well as general industries that include mining and ore processing, pharmaceuticals, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was founded in 1912 and is headquartered in Irving, Texas.
8×8, Inc. (EGHT) continued its downward trend with the stock declining -1% or $-0.15 to close the day at $14.85 on light trading volume of 1.99M shares, compared to its three month average trading volume of 631.62K. The San Jose California 95131 based company has been outperforming the diversified communication services group over the past 52 weeks, with the stock gaining 35.62%, compared to the industry which has dropped -2.47% over the same period. With RSI of 39.56, the stock should still continue to rise and get closer to its one year target estimate of $18.2, making it a hold for now.
8×8, Inc. provides cloud-based, enterprise-class software solutions for small and medium businesses, mid-market, and distributed enterprises worldwide. The company operates in two segments, Americas and Europe. The company’s pure-cloud offering combines voice, conferencing, messaging, and video with integrated workflows and big data analytics on a single platform. It provides 8×8 Virtual Office, a voice as a service with a robust business feature set; 8×8 Virtual Office Pro software that enables employees and workgroups to communicate with each other using chat or text messages sent via the short message service; 8×8 Virtual Contact Center, a voice, chat, voicemail, and e-mail call center. The company integrates its services with third-party applications and platforms, including enterprise resource planning, customer relations management, human capital management, and other proprietary application suites. It markets its services to end users through direct sales force, Website, and channel partners. The company serves approximately 45,700 business customers. 8×8, Inc. was founded in 1987 and is headquartered in San Jose, California.
TherapeuticsMD, Inc. (TXMD) shares were up in last trading by 0.51% to $5.89. It experienced lighter than average volume on day. The stock decreased in value by almost -0.67% over the past week and grew 2.61% in the past month. It is currently trading -0.14% below its 50 day moving average and -15.54% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -36.6% decrease in value from its one year high of $9.29. The RSI indicator value of 55.88, lead us to believe that it is a hold for now.
TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space, as well as directly through its Website. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.